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Host antiviral responses are initiated through 
the detection of viral components by host pat-
tern recognition receptors (PRRs) (1, 2). Upon 
recognition, PRRs trigger signaling that results 
in expression of type I IFN, IFN-stimulated 
genes, and infl  ammatory cytokines that suppress 
viral replication and facilitate adaptive immune 
responses (3, 4). Double-stranded (ds)RNA, 
which is produced during replication of many 
viruses, is one of the viral components recog-
nized by several PRRs, including Toll-like 
  receptor (TLR)3 and the RNA helicases, 
namely retinoic acid–inducible gene I (RIG-I) 
and melanoma diff  erentiation-associated  gene 
5 (Mda5) (also known as Helicard) (5–9). TLR3 
is a membrane-bound protein that resides in 
an endosomal membrane where it recognizes 
dsRNA and polyinosinic-polycytidylic acid 
(poly I:C), a synthetic analogue of dsRNA (5). 
RIG-I and Mda5 detect dsRNA and poly I:C 
in the cytoplasm (6, 7, 9). These helicases con-
tain two Caspase-recruiting domains (CARDs) 
that are essential for initiating downstream 
  signaling and the RNA helicase domain that 
mediates the recognition of dsRNA. Genetic 
studies revealed that RIG-I is required for 
  triggering antiviral responses against Newcastle 
disease virus (NDV), vesicular stomatitis virus 
(VSV), and Sendai virus (SeV) (8), whereas 
Mda5 is required for the responses against en-
cephalomyocarditis virus (EMCV) (9). Further-
more, RIG-I and Mda5 are required for the 
responses to in vitro transcribed dsRNA and 
poly I:C, respectively (9). Therefore, RIG-I and 
Mda5 recognize diff   erent structures of RNA 
and play major roles in the elimination of RNA 
viruses in vivo. Importantly, the RIG-I– and 
Mda5–dependent pathways are essential in the 
induction of type I IFN and infl  ammatory 
  cytokines after the RNA virus infection in most 
types of cells with the exception of plasma-
cytoid DCs where the detection of viruses is 
largely dependent on TLR7 and TLR9 that 
recognize viral single-stranded RNA and CpG 
DNA, respectively (1, 2, 8–15).
IFN-β promoter stimulator (IPS)-1, also 
known as mitochondrial antiviral signal-
ing   protein (MAVS), virus-induced signaling 
adaptor (VISA), and CARD adaptor induc-
ing IFN-β (Cardif), was recently identifi  ed 
as an adaptor linking RIG-I and Mda5 to 
the downstream signaling molecules (16–19). 
IPS-1 contains the CARD-like domain that 
is   responsible for the interaction with that of 
RIG-I and Mda5. In addition, IPS-1 contains 
a transmembrane region that targets this protein 
to the   mitochondrial outer membrane (17). 
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mediated induction of type I interferon and infl  ammatory cytokines and were susceptible 
to RNA virus infection. RNA virus–induced interferon regulatory factor-3 and nuclear 
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essential for the responses to either DNA virus or double-stranded B-DNA. Thus, IPS-1 
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The mitochondrial localization of IPS-1 is essential for 
triggering downstream signaling, indicating a critical link 
between mitochondria and antiviral immunity. IPS-1 is 
capable of activating interferon regulatory factor (IRF)-3 
and IRF-7. Both IRF-3 and IRF-7 reside in cytoplasm in 
nonstimulated cells. Upon virus infection, these IRFs are 
phosphorylated by TANK-binding kinase 1 and inducible 
inhibitor of κB kinase to translocate to the nucleus and regu-
late expression of genes encoding type I IFN (20, 21). IPS-1 
also activates NF-κB that controls the expression of genes 
encoding infl   ammatory responses via IKKα- and IKKβ-
  mediated phosphorylation and destruction of IκBs (22). Fas-
  associated death domain, receptor-interacting protein 1, and 
Caspase-8 are suggested to be involved in IPS-1–mediated 
pathway (23, 24). However, the contribution of IPS-1 in RIG-
I– and Mda5-dependent signaling and in antiviral immune 
responses in vivo remains unclear.
In the present study, we provide evidence for the critical 
role of IPS-1 in antiviral responses in vivo. IPS-1–defi  cient 
mice displayed defective induction of type I IFN and infl  am-
matory cytokines after infection with various RNA viruses 
and were susceptible to the RNA virus infection. Further-
more, IPS-1–defi  cient cells were unable to activate NF-κB 
and IRF-3 in response to NDV. On the other hand, IPS-1 
was not essential for the responses to either DNA virus or 
double-stranded B-form DNA. Collectively, these results 
demonstrate that IPS-1 is an essential component in both 
RIG-I– and Mda5-dependent signaling that triggers the host 
response to infection with various RNA viruses.
RESULTS
Generation of IPS-1–defi  cient mice
We generated IPS-1–defi  cient mice by the standard gene tar-
geting. We designed a targeting vector to disrupt two exons 
harboring the CARD-like domain of IPS-1, which is required 
for signaling (Fig. 1 A). The heterozygosity and homozygosity 
of obtained mice were verifi  ed by Southern blot analysis (Fig. 
1 B), and the nullizygosity was confi  rmed by Northern blot 
and immunoblot analyses (Fig. 1, C and D). Mutant mice 
  homozygous for the disrupted Ips-1 allele were born at the ex-
pected Mendelian ratio and grew healthy in specifi  c pathogen-
free conditions. No obvious change in hematopoietic cell 
development was observed in IPS-1–defi  cient mice as deter-
mined by FACS analysis (unpublished data).
Role of IPS-1 in RIG-I–dependent responses
We fi  rst asked whether or not IPS-1 is required for anti-
viral responses against single-stranded RNA viruses. We used 
NDV, VSV lacking a variant of M protein (NCP), and SeV 
with mutated C proteins (Cm) as model viruses for RIG-I– 
dependent responses (8, 9). Mutant VSV and SeV induce type 
I IFN in mouse embryonic fi  broblast cells (MEFs) caused 
by an inability to inhibit host IFN responses. Production 
of IFN-β, IFN-α, and IL-6 after these viruses’ infection 
was   severely impaired in MEFs prepared from IPS-1–
defi  cient mice, as measured by ELISA (Fig. 2 A). Failure of 
these   cytokines’ induction was also observed in peritoneal 
macrophages (PECs) and granulocyte/macrophage colony-
stimulating factor (GM-CSF)–generated bone marrow–
  derived dendritic cells (GM-DCs) from IPS-1–defi  cient mice 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
20060792/DC1). Induction of mRNA encoding IFN-α 
(Ifna), IFN-β ( Ifnb), IFN-inducible genes (IP-10 [Cxcl10] 
and RANTES [Ccl5]), and IL-6 (Il6) in response to these 
viruses was also impaired in IPS-1–defi  cient MEFs (Fig. 2 B). 
We next examined surface expression of costimulatory mol-
ecules on DCs, a process required for induction of adaptive 
immune responses. Surface expression of CD86 after VSV 
NCP infection was not observed in conventional DCs (Flt3 
ligand–generated bone marrow–derived DCs with B220−) 
from IPS-1–defi  cient mice (Fig. 2 C). In contrast, surface ex-
pression of CD86 in response to A/D-type CpG DNA (D35), 
a ligand for TLR9, was normal in IPS-1–defi  cient DCs (Fig. 
2 C). Surface expression of CD40 was also impaired in VSV-
infected IPS-1–defi  cient DCs (unpublished data).
Figure 1.  Generation of IPS-1–defi  cient mice. (A) The genomic 
structure of murine IPS-1 gene, the targeting vector, and the predicted 
mutated allele are shown. Black and white boxes denote the coding and 
noncoding exons, respectively. E, EcoRI. (B) Southern blot analysis of off-
springs from the heterozygote intercrosses. Genomic DNA was extracted, 
digested with EcoRI, electrophoresed, and hybridized with a probe indicated 
in A. The blotting gave a single 11.3-kb band for wild-type (+/+), a 7.0-kb 
band for homozygous mutants (−/−), and both bands for heterozygous 
mice (+/−). (C) Northern blot analysis for the expression of IPS-1 gene. 
Total RNA (30 μg) was extracted from MEFs prepared from wild-type (+/+) 
and homozygous mutant (−/−) mice, electrophoresed, and hybridized 
with an IPS-1 (Ips-1) or β-actin (Actb) probe. (D) Immunoblot analysis for 
the expression of IPS-1 protein. Four independent MEFs were lysed and 
immunoprecipitated with anti–IPS-1 antibody (IP) and then blotted with 
anti–IPS-1 antibody (IB). The whole cell lysates (WCL) were simultaneously 
blotted with anti–extracellular signal-regulated kinase 1/2 antibody.JEM VOL. 203, July 10, 2006  1797
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In vitro transcribed dsRNA is shown to induce type I 
IFN in a manner dependent on RIG-I (9). We next synthe-
sized diff  erent lengths of dsRNA (200, 400, and 600 bp) and 
stimulated wild-type and IPS-1–defi  cient MEFs with these 
RNA by transfection. IPS-1–defi  cient MEFs did not pro-
duce IFN-β in response to any length of dsRNA tested (Fig. 
2 D). Collectively, these observations demonstrate that IPS-1 
is required for RIG-I–mediated responses.
Because members of TLRs have been shown to recog-
nize viral components and participate in type I IFN induc-
tion, we next examined responses of IPS-1–defi  cient mice to 
TLR ligands. We examined TLR9-mediated responses using 
splenocytes, which contain plasmacytoid DCs that produce 
type I IFN in response to the TLR9 ligand. IFN-β and IFN-α 
production after D35 stimulation was comparable between 
wild-type and IPS-1–defi  cient splenocytes (Fig. 2 E). Induc-
tion of Cxcl10 and Il6 mRNA after stimulation with LPS, 
a TLR4 ligand, was also comparable between wild-type and 
IPS-1–defi  cient MEFs (Fig. 2 F). Thus, IPS-1 is not involved 
in TLR-mediated type I IFN induction.
Role of IPS-1 in Mda5-dependent responses
We next examined Mda5-mediated responses using EMCV 
and poly I:C (9). Type I IFN after EMCV infection was abol-
ished in PECs derived from IPS-1–defi  cient mice (Fig. 3 A). 
Although IL-6 induction was observed in the absence of IPS-1, 
the induction was reduced compared with wild-type cells (Fig. 
3 A). Induction of genes encoding IFN-α, IFN-β, IP-10, 
RANTES, and IL-6 was also reduced in IPS-1–defi  cient PECs 
(Fig. 3 B). Type I IFN and infl  ammatory cytokines are induced 
in MEFs when poly I:C is administrated into the cytoplasm by 
lipofection. Notably, this induction is independent of TLR3 
but dependent on Mda5 (9, 25). Production of IFN-β, IFN-α, 
and IL-6 after poly I:C transfection was markedly reduced 
in IPS-1–defi   cient MEFs in comparison to wild-type cells 
(Fig. 3 C). Similarly, Ifnb, Ifna, Cxcl10, and Il6 induction was 
Figure 2.  Impaired responses of IPS-1–defi  cient cells to various 
RNA viruses. (A and B) MEFs from wild type (+/+) and IPS-1–defi  cient 
mice (−/−) were infected with NDV (multiplicity of infection [moi] = 1.0), 
VSV NCP mutant (VSV; moi =0.1); or SeV Cm mutant (SeV; moi = 0.1). 
After 24 h, the concentration of the cytokines in the culture supernatant 
was measured by ELISA (A). After incubation for the indicated period, total 
RNAs was extracted and subjected to Northern blot analysis to determine 
the expression pattern of the respective genes (B). Asterisks indicate not 
detected. Indicated values are means ± SD of triplicates. (C) B220− CD11c+ 
FL-DCs were infected with VSV NCP (moi = 1.0) or stimulated with 
3 μM D35. After 24 h, cells were fi  xed and stained with anti-CD86 antibody. 
(D) MEFs from wild-type (+/+) and IPS-1–defi  cient mice (−/−) were 
stimulated with the indicated length of dsRNA. After 24 h, the concentra-
tion of IFN-β in the culture supernatant was measured by ELISA. Asterisks 
indicate not detected. Indicated values are means ± SD of triplicates. 
(E) Splenocytes were stimulated with D35. After 24 h, the concentration 
of the cytokines in the culture supernatant was measured by ELISA. Asterisks 
indicate not detected. Indicated values are means ± SD of triplicates. 
(F) MEFs were stimulated with 10 μg/ml LPS. After 2, 4, and 6 h, the 
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severely impaired in IPS-1–defi  cient MEFs (Fig. 3 D). Impaired 
IFN-β and IL-6 induction upon poly I:C transfection also ob-
served in IPS-1–defi  cient GM-DCs where poly I:C–mediated 
  responses are also dependent on Mda5 but not TLR3 (Fig. S2, 
http://www.jem.org/cgi/content/full/20060792/DC1) (9). 
Similar to Mda5-defi   cient mice, induction of IFN-β and 
IL-6 was also impaired in IPS-1–defi  cient GM-DCs when 
poly I:C was given to the culture medium (unpublished data; 
reference 9). We next challenged the mice with poly I:C and 
measured cytokine production in sera. Whereas wild-type 
mice showed rapid induction of serum IFN-α, IFN-β, and 
IL-6, the induction was remarkably reduced in IPS-1–  defi  cient 
mice (Fig. 3 E). Collectively, these results indicate that IPS-1 
is essential for Mda5-mediated responses.
Impaired activation of NF-𝗋B and IRF-3 in response 
to NDV infection in IPS-1–defi  cient cells
We next examined activation of signaling pathways after 
virus infection. IPS-1–defi  cient MEFs displayed severely 
  impaired induction of NF-κB–DNA binding after NDV in-
fection, whereas they showed comparable induction of the 
binding activity with wild-type cells when stimulated with 
LPS (Fig. 4 A). Nuclear translocation of RelA, a component 
of NF-κB, was also diminished in IPS-1–defi  cient cells (Fig. 
4 B). Induction of an IRF-3 dimer formation after NDV in-
fection was not observed in IPS-1–defi  cient MEFs (Fig. 4 C). 
Furthermore, tyrosine phosphorylation of STAT1, which is 
induced by secreted type I IFN, was abolished in IPS-1–
  defi  cient MEFs (Fig. 4 D). Up-regulation of IRF-7, which is 
also involved in type I IFN induction by cooperating with 
IRF-3, was also abrogated in IPS-1–defi  cient cells (Fig. 4 E). 
Collectively, IPS-1 is indispensable for NDV-induced activa-
tion of IRF-3 and NF-κB.
IPS-1–defi  cient mice are susceptible to EMCV 
and VSV infection
To gain insights into the biological relevance of IPS-1 in 
  virus infection-mediated responses in vivo, we challenged 
Figure 3.  Impaired responses of IPS-1–defi  cient cells to EMCV 
and poly (I:C). (A and B) PECs isolated from wild-type and IPS-1–  defi  cient 
mice were infected with EMCV (moi = 0.1). After 24 h, cytokine production 
in the culture supernatant was measured by ELISA (A). After 6 and 9 h, total 
RNA was extracted and subjected to RT-PCR analysis for the expression of 
respective genes (B). Asterisks indicate not detected. Indicated values are 
means ± SD of triplicates. (C) MEFs were transfected with the indicated 
concentrations of poly I:C (pIC). After 24 h, cytokine production in the cul-
ture supernatant was measured by ELISA. Asterisks indicate not detected. 
Indicated values are means ±SD of   triplicates. (D) MEFs were transfected 
with 10 μg/ml poly I:C and incubated for the indicated periods. Total RNA 
was subjected to Northern blot analysis for the expression of relevant 
genes. (E) IPS-1+/− and IPS-1−/− mice were intravenously challenged with 
poly I:C (200 μg/body). Sera were prepared before injection (0 h) or after 2, 
4, and 8 h, and the concentration of the cytokines was   measured by ELISA. 
Similar results were obtained from three independent experiments.JEM VOL. 203, July 10, 2006  1799
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mice with EMCV to measure serum cytokines. Production 
of cytokines, including IFN-β, IFN-α, IL-6, IP-10, and 
MCP-1, was severely impaired in IPS-1–defi  cient mice (Fig. 
5 A). We next examined the susceptibility of IPS-1–defi  cient 
mice to EMCV infection. IPS-1–defi  cient mice were more 
susceptible to EMCV infection than control mice (P < 0.05) 
(Fig. 5 B). In accordance with the increased susceptibility to 
EMCV, virus titer in the heart of IPS-1–defi  cient mice was 
higher than control mice, which was similar to that observed 
in Mda5-defi  cient mice (Fig. 5 C) (9). Furthermore, we ob-
served that IPS-1–defi  cient mice succumbed to VSV infec-
tion (Fig. 5 D), and virus titer in the liver and brain was 
markedly higher in IPS-1–defi  cient mice than wild-type 
mice (Fig. 5 E). Collectively, these observations indicate that 
IPS-1 is indispensable for humoral responses in vivo against 
EMCV and VSV infection.
Role of IPS-1 in B-DNA– and DNA virus–mediated responses
Because IPS-1 is implicated in B-DNA–mediated responses, 
we next examined the contribution of IPS-1 to this pathway 
(26, 27). Production of IFN-β after B-DNA transfection was 
slightly reduced ( 40%) in IPS-1–defi  cient MEFs compared 
with wild-type cells (Fig. 6 A). However, no remarkable re-
duction of IP-10 and IL-6 was observed in IPS-1–defi  cient 
cells (Fig. 6 A). In Northern blot analysis, there was no reduc-
tion of Cxcl10, Il6, and Ccl5 expression in any time course 
examined in IPS-1–defi  cient MEFs, whereas the induction 
of Ifnb was slightly reduced after stimulation compared with 
wild-type MEFs (Fig. 6 B), suggesting that IPS-1 is partially 
involved in early phase induction of IFN-β. We next exam-
ined DNA virus–mediated responses. To this end, we used 
a modifi  ed vaccinia virus, Ankara (MVA), lacking E3 ligase 
(∆E3L) which encodes a poxvirus regulatory protein critical 
for inhibiting host type I IFN responses (26). IPS-1–defi  cient 
MEFs displayed reduced induction of IFN-β in response to 
MVA ∆E3L at 24 h compared with wild-type MEFs (Fig. 6 C). 
In contrast, IL-6 induction was comparable between wild-
type and IPS-1–defi  cient MEFs (Fig. 6 C). These fi  ndings 
suggest that IPS-1 is not essential for MVA-mediated responses 
but is required for the maximal induction of IFN-β. We next 
examined the amounts of viral protein from MVA ∆E3L-
  infected MEFs by immunoblot analysis of total cell lysates us-
ing anti-MVA antibody (Fig. 6 D). MVA protein was elevated 
at 24 h and decreased by 48 h after infection in wild-type 
MEFs (Fig. 6 D). In IPS-1–defi  cient MEFs, elevated levels of 
MVA protein were still observed at 48 h (Fig. 6 D), suggesting 
that IPS-1 is partially involved in the elimination of MVA.
DISCUSSION
In this study, we examined the physiological role of IPS-1 
through the generation of IPS-1–defi  cient mice. We showed 
that IPS-1 is indispensable for responses against various single-
stranded RNA viruses, including NDV, VSV, and SeV, 
all of which are recognized by RIG-I. The induction of 
type I IFN, IFN-stimulated genes, and infl  ammatory cyto-
kines are abrogated in various cell types, including MEFs, 
PECs, and conventional DCs, and the up-regulation of 
CD86 is impaired in IPS-1–defi   cient conventional DCs. 
IPS-1–defi  cient mice also show severe defects in the re-
sponses to EMCV, which is recognized by Mda5. Further-
more, IPS-1 is essential to the induction of type I IFN 
in response to dsRNA and poly I:C that are recognized 
by RIG-I and Mda5, respectively. In agreement with the in 
vitro studies showing that overexpression of IPS-1 activates 
IFN-β and NF-κB promoters, IPS-1–defi  cient cells fail to 
activate IRF-3 and NF-κB in response to NDV. Thus, IPS-1 
is the sole adaptor in both RIG-I– and Mda5-dependent 
signaling pathways.
Figure 4.  Impaired NF-𝗋B and IRF-3 activation in response to 
NDV in IPS-1–defi  cient cells. (A–E) Wild-type and IPS-1–defi  cient MEFs 
were incubated for the indicated periods after NDV infection (moi = 0.1) 
or LPS (10 μg/ml) stimulation. Nuclear extracts were subjected to electro-
phoretic mobility shift assay using an NF-κB–specifi  c probe (A) and 
immunoblot analysis using anti-RelA antibody (B). Whole cell lysates 
were subjected to native page analysis using anti–IRF-3 antibody (C) and 
immunoblot analysis using anti-phospho STAT1 (p-STAT1) and anti-STAT1 
antibodies (D). Total RNA was subjected to RT-PCR analysis for the expres-
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In addition to RIG-I and Mda5, certain members of 
TLRs, including TLR3, TLR4, TLR7, and TLR9 also rec-
ognize viral components to induce type I IFN and infl  amma-
tory cytokines (1, 2). TLR7 and TLR9 recruit an adaptor 
MyD88, which subsequently forms a signaling complex with 
a protein kinase IRAK1 and IRF-7 that mediates induction 
of type I IFN (28–31). TLR3 and TLR4 induce type I IFN 
through TIR domain–containing adaptor-inducing IFN-β 
(TRIF), which interacts with TANK-binding kinase 1 and 
IRF-3 (32–34). Furthermore, a previous report demonstrated 
that IPS-1 interacts with TRIF (18), suggesting an involve-
ment of IPS-1 in TLR-mediated signaling. In IPS-1– defi  cient 
cells, however, both TLR9- and TLR4-mediated induction 
of cytokines are normal, indicating that IPS-1 is not involved 
in TLR-mediated antiviral responses.
Induction of IL-6 after infection with EMCV is still 
  observed in IPS-1–defi  cient PECs, although the induction is 
reduced when compared with that of wild-type cells. Simi-
larly, there is a small induction of serum cytokines after poly 
I:C administration in IPS-1–defi  cient mice. Since poly I:C, 
viral nucleic acids, and viral glycoproteins can be recognized 
by members of TLRs, the residual induction of IL-6 might 
be mediated by the activation of TLR-mediated pathways. 
Generation of IPS-1/MyD88 and IPS-1/TRIF doubly defi  -
cient mice will be required to clarify the relationships   between 
the RIG-I/Mda5- and TLR-mediated pathways in virus 
  infection-mediated cytokine induction. Also, these mice will 
be useful to understand the specifi  c or overlapping role of the 
IPS-1–, MyD88- and TRIF-dependent pathways in the in-
duction of antiviral innate immune responses and subsequent 
induction of adaptive immune responses.
Notably, IPS-1 is not essential in B-DNA– or DNA 
  virus–mediated responses. We have previously shown that 
knockdown of IPS-1 in HEK293 cells partially abrogated B-
DNA–dependent IFN-β promoter activation (26, 27). How-
ever, IFN-β induction in response to B-DNA was still 
observed in IPS-1–defi  cient MEFs, although the induction 
was slightly decreased in the early phase (approximately 40% 
reduced). These aspects strongly suggest that cells possess a 
yet unidentifi  ed adaptor that is unique to dsDNA sensor(s). 
In response to MVA infection, IFN-β induction was   reduced 
in IPS-1–defi  cient cells, and the elimination of   viruses in 
IPS-1–defi  cient cells was consistently delayed compared with 
wild-type cells. However, dsRNA might be generated as a 
by-product of symmetrical transcription in DNA viruses. 
Thus, it is possible that reduced IFN-β in IPS-1–defi  cient 
cells is due to a lack of responses of these cells to dsRNA.
IPS-1 was shown to localize to mitochondria, suggest-
ing a role of IPS-1 in the regulation of apoptosis, which 
is important for the host defense to virus infection (17). 
Figure 5.  Role of IPS-1 in in vivo antiviral responses. (A) Wild-type 
and IPS-1–defi  cient mice (n = 2) were intravenously injected with EMCV 
(107 PFU). Sera were collected 4 h after injection, and the cytokine level was 
measured by ELISA. Data are presented from one representative experiment 
of two independent experiments. (B) Wild-type and IPS-1–defi  cient mice 
(n = 7) were intraperitoneally infected with EMCV (102 PFU). The survival 
of these mice was monitored for up to 4 d. (C) IPS-1+/− and IPS-1−/− (n = 3) 
were intraperitoneally infected with EMCV (102 PFU). After 48 h of infec-
tion, virus yield in the heart was quantifi  ed by plaque assay. (D) Wild-type 
and IPS-1–defi  cient mice (n = 6) were intranasally infected with VSV 
(4 × 106 PFU). The survival of these mice was monitored for up to 9 d. 
(E) Wild-type and IPS-1–defi  cient mice (n = 2) were intranasally infected 
with VSV (4 × 106 PFU). After 72 h of infection, virus yield in the liver and 
brain was quantifi  ed by plaque assay. Asterisks indicate not detected.JEM VOL. 203, July 10, 2006  1801
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  However, cell death induction in response to VSV infection 
or poly I:C stimulation was comparable between wild-type 
and IPS-1–defi  cient MEFs (Fig. S3, available at http://www.
jem.org/cgi/content/full/20060792/DC1). This fi  nding in-
dicates that virus-induced cell death does not require IPS-1. 
Rather, the localization of IPS-1 to the   mitochondria is es-
sential for type I IFN induction in virus-infected cells.
Finally, it is possible that the IPS-1–dependent pathway is 
central to antiviral responses against a wide variety of RNA 
viruses. Conversely, numerous viruses may have evasion mecha-
nisms that counteract the IPS-1–dependent pathway. Indeed, 
HCV NS3/4A protease reportedly cleaves IPS-1 at C508, 
releasing IPS-1 from mitochondria that results in loss of 
IRF-3 activation and type I IFN induction (19, 35, 36). 
Therefore, development of drugs that control the IPS-1–
  dependent pathway would be therapeutically useful against 
infectious diseases caused by RNA viruses.
MATERIALS AND METHODS
Generation of IPS-1–defi  cient mice. The IPS-1 gene was isolated from 
genomic DNA extracted from embryonic stem cells (GSI-I) by PCR. The 
targeting vector was constructed by replacing a 1.8-kb fragment encoding 
the IPS-1 open reading frame (exons 1 and 2) with a neomycin-resistance 
gene cassette (neo), and a herpes simplex virus thymidine kinase (HSV-TK) 
driven by the PGK promoter was inserted into the genomic fragment for 
negative selection. After the targeting vector was transfected into ES cells, 
G418 and gancyclovir doubly resistant colonies were selected and screened 
by PCR and further confi  rmed by Southern blot analysis. Homologous 
  recombinants were microinjected into C57BL/6 female mice, and heterozy-
gous F1 progenies were intercrossed to obtain IPS-1−/− mice. Mice were 
bred and maintained in a specifi  c pathogen-free facility of Research Institute 
for Microbial Diseases in accordance with the specifi  cations of the Associa-
tion for Assessment and Accreditation of Laboratory Animal Care. Mouse 
protocols were approved by the Osaka University Animal Care and Use 
Committee. All mice were killed at 5–9 wk of age.
Cells, viruses, and reagents. MEFs were prepared from day 13.5 to 
14.5 embryos. PECs from mice were collected 3 d after intraperitoneal 
injection with 4% thioglycollate medium. Bone marrow cells were cul-
tured in RPMI 1640 medium supplemented with 10% FCS, 100 mM 2-
ME, and 100 ng/ml human Flt3 ligand (PeproTech), or 10 ng/ml murine 
GM-CSF (PeproTech) for 6–8 d to use as FL- DCs and GM-DCs, respec-
tively. B220− CD11c+ FL-DCs were isolated from FL-DCs by MACS 
using anti-B220 antibody microbeads from Miltenyi Biotech as described 
previously (26). NDV, VSV NCP, SeV Cm, EMCV, and MVA Ankara 
∆E3L were provided by T. Abe and Y. Matsuura (Research Institute for 
Microbial Diseases), T. Fujita   (Institute for Virus Research, Kyoto Uni-
versity, Kyoto, Japan), and H. Ludwig and G. Sutter (Paul-Ehrlich Insti-
tute, Langen, Germany) and described previously (8, 9, 26). LPS from 
Salmonella minnesota Re-595 was purchased from Sigma-Aldrich. Syn-
thetic ds B-DNA (poly[dA-dT]·poly[dT-dA]) and poly I:C were pur-
chased from GE Healthcare. A/D-type CpG DNA (D35) was described 
previously (31). In vitro–transcribed dsRNA was prepared from the mouse 
Lamin A/C cDNA sequence as described previously (9). For stimulation 
of cells, B-DNA or poly I:C was mixed with Fugene 6 transfection re-
agent (Roche) at a ratio of 1:1 (vol/wt) in OptiMEM and   incubated for 
15 min before stimulation. Anti–extracellular signal-regulated kinase 1/2, 
anti-RelA, anti–IRF-3, and anti-STAT1 antibodies were   purchased from 
Santa Cruz Biotechnology, Inc. Anti–phospho-STAT1   antibody was pur-
chased from Cell Signaling. Polyclonal rabbit anti-MVA antibody was 
purchased from Biogenesis. Anti–IPS-1 antibody was generated in rabbits 
by immunizing synthetic peptides that correspond to amino acids 425–
438 of mouse IPS-1 as immunogens.
Figure 6.  Role of IPS-1 in B-DNA–mediated responses. (A and B) 
Wild-type and IPS-1–defi  cient MEFs were transfected with 10 μg/ml 
B-DNA. After 24 h, the concentration of IFN-β, IP-10, and IL-6 was mea-
sured by ELISA (A). After 2, 4, and 6 h, total RNA was extracted and sub-
jected to Northern blot analysis to determine the expression pattern of 
the respective genes (B). Asterisks indicate not detected. Indicated values 
are means ± SD of triplicates. (C and D) MEFs were infected with 107 PFU 
MVA ∆E3L . After 24 and 48 h incubation, the concentration of IFN-β and 
IL-6 was measured by ELISA (C). Whole cell lysates were subjected to 
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ELISA. Culture supernatants of cells (105) seeded on 24-well plates or   serum 
were collected and analyzed for cytokine levels with ELISA. ELISA kits for 
IFN-β and IFN-α were purchased from PBL Biomedical Laboratories. IL-6, 
IP-10, and MCP-1 ELISA kits were purchased from R&D Systems. ELISA 
was performed according to the manufacturer’s instructions.
Northern blot analysis. Total RNA was extracted using Trizol reagent 
(Invitrogen), electrophoresed, transferred onto nylon membranes, and then 
hybridized with the indicated cDNA probe. The full-length IPS-1 cDNA 
fragment was used as a probe to detect IPS-1 expression. Other probes were 
described previously (25).
RT-PCR. Total RNA was isolated with Trizol reagent (Invitrogen) and 
was reverse transcribed with SuperScript III reverse transcriptase (I  nvitrogen) 
according to the manufacturer’s instructions. PCR was then done with 
the following primers: IRF-7, 5′-T  C  G  G  T  C  G  T  A  G  G  G  A  T  C  T  G  G  -3′ and 
5′-G  G  C  C  T  G  G  G  A  C  T  G  G  G  G  A  C  A  -3′ and β-actin, 5′-G  A  C  A  T  G  G  A  G  A  A-
G  A  T  C  T  G  G  C  A  C  C  A  C  A  -3′ and 5′-A  T  C  T  C  C  T  G  C  T  C  G  A  A  G  T  C  T  A  G  A  G-
C  A  A  -3′. Details of other primers were described previously (26).
Immunoprecipitation, immunoblot, electrophoretic mobility shift 
assay, and Native-PAGE analyses. Immunoprecipitation, immunoblot, 
electrophoretic mobility shift assay, and Native-PAGE analyses were per-
formed as described previously (32, 34).
Plaque assay. 48 h after EMCV infection or 72 h after VSV infection,   tissues 
were taken and homogenized in PBS. Virus titration was determined by stan-
dard plaque assay as described previously (8, 9). In brief, after centrifugation, 
supernatants were serially diluted and added to HeLa (for EMCV) or BHK 
(for VSV) cells. The cells were overlaid with DMEM containing 1% low 
melting agarose and incubated for 48 h, and then plaques were counted.
Flow cytometric analysis of costimulatory molecule expressions. 
Cell surface expression of CD86 was analyzed as described previously (37). 
In brief, B220− FL-DCs were washed with ice cold PBS, fi  xed, and stained 
with FITC-, PE-, CyChrome- and APC-labeled antibodies in the presence 
of anti-CD16 for 30 min at room temperature. Stained cells were washed, 
resuspended in PBS/0.1% BSA/0.1% NaN3, and analyzed by FACSCalibur 
followed by analysis using CELLQuest software (Becton Dickinson). All anti-
bodies were obtained from Becton Dickinson.
Online supplemental material. Impaired induction of IFN-β and IL-6 
in response to NDV, VSV, or SeV infection in PECs and GM-DCs   derived 
from IPS-1–defi  cient mice is shown in Fig. S1. Impaired induction of IFN-
β and IL-6 in response to poly I:C stimulation in GM-DCs derived from 
IPS-1–defi  cient mice is shown in Fig. S2. Normal induction of cell death af-
ter VSV infection or poly I:C stimulation in IPS-1–  defi  cient MEFs is shown 
in Fig. S3. Online supplemental material is available at http://www.jem.
org/cgi/content/full/20060792/DC1.
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